432 related articles for article (PubMed ID: 15518912)
41. Distribution of vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide receptors (VPAC1, VPAC2, and PAC1 receptor) in the rat brain.
Joo KM; Chung YH; Kim MK; Nam RH; Lee BL; Lee KH; Cha CI
J Comp Neurol; 2004 Aug; 476(4):388-413. PubMed ID: 15282712
[TBL] [Abstract][Full Text] [Related]
42. PACAP and VIP affect NF1 expression in rat malignant peripheral nerve sheath tumor (MPNST) cells.
Giunta S; Castorina A; Adorno A; Mazzone V; Carnazza ML; D'Agata V
Neuropeptides; 2010 Feb; 44(1):45-51. PubMed ID: 19919880
[TBL] [Abstract][Full Text] [Related]
43. Cardioprotective role of the VIP signaling system.
Dvoráková MC
Drug News Perspect; 2005; 18(6):387-91. PubMed ID: 16247516
[TBL] [Abstract][Full Text] [Related]
44. Pituitary adenylate cyclase-activating polypeptide directly modulates the activity of proopiomelanocortin neurons in the rat arcuate nucleus.
Mounien L; Bizet P; Boutelet I; Gourcerol G; Fournier A; Vaudry H; Jégou S
Neuroscience; 2006 Nov; 143(1):155-63. PubMed ID: 16962718
[TBL] [Abstract][Full Text] [Related]
45. Intestinal adaptation in atrophic rat ileum is accompanied by supersensitivity to vasoactive intestinal peptide, pituitary adenylate cyclase-activating peptide and nitric oxide.
Ekelund M; Ekblad E
Scand J Gastroenterol; 2001 Mar; 36(3):251-7. PubMed ID: 11305511
[TBL] [Abstract][Full Text] [Related]
46. Analysis of the role of the PAC1 receptor in neutrophil recruitment, acute-phase response, and nitric oxide production in septic shock.
Martínez C; Juarranz Y; Abad C; Arranz A; Miguel BG; Rosignoli F; Leceta J; Gomariz RP
J Leukoc Biol; 2005 May; 77(5):729-38. PubMed ID: 15661828
[TBL] [Abstract][Full Text] [Related]
47. Vasoactive intestinal peptide (VIP) stimulates rat prostatic epithelial cell proliferation.
Juarranz MG; Bodega G; Prieto JC; Guijarro LG
Prostate; 2001 Jun; 47(4):285-92. PubMed ID: 11398176
[TBL] [Abstract][Full Text] [Related]
48. Coronary vascular effects of vasoactive intestinal peptide in the isolated perfused rat heart.
Sawmiller DR; Henning RJ; Cuevas J; Dehaven WI; Vesely DL
Neuropeptides; 2004 Oct; 38(5):289-97. PubMed ID: 15464194
[TBL] [Abstract][Full Text] [Related]
49. Vasoactive intestinal peptide (VIP) receptor expression in monocyte-derived macrophages from COPD patients.
Burian B; Storka A; Marzluf BA; Yen YC; Lambers C; Robibaro B; Vonbank K; Mosgoeller W; Petkov V
Peptides; 2010 Apr; 31(4):603-8. PubMed ID: 20026142
[TBL] [Abstract][Full Text] [Related]
50. [Neuroprotective effects of novel derivatives of vasoactive intestinal peptide and pituitary adenylate cyclase-activating peptide in two brain ischemic models on mice].
Takeda N; Murozono M; Watanabe S; Isshiki A; Watanabe Y
Masui; 2005 Mar; 54(3):240-8. PubMed ID: 15794099
[TBL] [Abstract][Full Text] [Related]
51. A lymphocyte-generated fragment of vasoactive intestinal peptide with VPAC1 agonist activity and VPAC2 antagonist effects.
Summers MA; O'Dorisio MS; Cox MO; Lara-Marquez M; Goetzl EJ
J Pharmacol Exp Ther; 2003 Aug; 306(2):638-45. PubMed ID: 12750439
[TBL] [Abstract][Full Text] [Related]
52. Differential expression of mRNAs for PACAP and its receptors during neural differentiation of embryonic stem cells.
Hirose M; Hashimoto H; Shintani N; Nakanishi M; Arakawa N; Iga J; Niwa H; Miyazaki J; Baba A
Regul Pept; 2005 Mar; 126(1-2):109-13. PubMed ID: 15620423
[TBL] [Abstract][Full Text] [Related]
53. Development of simplified vasoactive intestinal peptide analogs with receptor selectivity and stability for human vasoactive intestinal peptide/pituitary adenylate cyclase-activating polypeptide receptors.
Igarashi H; Ito T; Mantey SA; Pradhan TK; Hou W; Coy DH; Jensen RT
J Pharmacol Exp Ther; 2005 Oct; 315(1):370-81. PubMed ID: 15994369
[TBL] [Abstract][Full Text] [Related]
54. Vasoactive intestinal peptide inhibits toll-like receptor 3-induced nitric oxide production in Schwann cells and subsequent sensory neuronal cell death in vitro.
Lee H; Park K; Kim JS; Lee SJ
J Neurosci Res; 2009 Jan; 87(1):171-8. PubMed ID: 18683246
[TBL] [Abstract][Full Text] [Related]
55. Elucidation of the vasoactive intestinal peptide pharmacophore for VPAC(2) receptors in human and rat and comparison to the pharmacophore for VPAC(1) receptors.
Igarashi H; Ito T; Pradhan TK; Mantey SA; Hou W; Coy DH; Jensen RT
J Pharmacol Exp Ther; 2002 Nov; 303(2):445-60. PubMed ID: 12388623
[TBL] [Abstract][Full Text] [Related]
56. Alfa 1 adrenergic potentiation of progesterone accumulation stimulated by vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activating polypeptide (PACAP) in cultured rat granulosa cells.
Wasilewska-Dziubiñska E; Borowiec M; Chmielowska M; Woliñska-Witort E; Baranowska B
Neuro Endocrinol Lett; 2002 Apr; 23(2):141-8. PubMed ID: 12011800
[TBL] [Abstract][Full Text] [Related]
57. Differential expression of vasoactive intestinal peptide and its functional receptors in human osteoarthritic and rheumatoid synovial fibroblasts.
Juarranz Y; Gutiérrez-Cañas I; Santiago B; Carrión M; Pablos JL; Gomariz RP
Arthritis Rheum; 2008 Apr; 58(4):1086-95. PubMed ID: 18383383
[TBL] [Abstract][Full Text] [Related]
58. Characterization of novel splice variants of the PAC1 receptor in human neuroblastoma cells: consequences for signaling by VIP and PACAP.
Lutz EM; Ronaldson E; Shaw P; Johnson MS; Holland PJ; Mitchell R
Mol Cell Neurosci; 2006 Feb; 31(2):193-209. PubMed ID: 16226889
[TBL] [Abstract][Full Text] [Related]
59. Pharmacological characterization of VIP and PACAP receptors in the human meningeal and coronary artery.
Chan KY; Baun M; de Vries R; van den Bogaerdt AJ; Dirven CM; Danser AH; Jansen-Olesen I; Olesen J; Villalón CM; MaassenVanDenBrink A; Gupta S
Cephalalgia; 2011 Jan; 31(2):181-9. PubMed ID: 20974589
[TBL] [Abstract][Full Text] [Related]
60. Inhalable sustained-release formulation of long-acting vasoactive intestinal peptide derivative alleviates acute airway inflammation.
Onoue S; Matsui T; Kuriyama K; Ogawa K; Kojo Y; Mizumoto T; Karaki S; Kuwahara A; Yamada S
Peptides; 2012 Jun; 35(2):182-9. PubMed ID: 22484228
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
